Phase I dose finding study evaluating the combination of bendamustine with weekly paclitaxel in patients with pre-treated metastatic breast cancer: RiTa trial

Sibylle Loibl; Caroline Murmann; Katrin Schwedler; Mathias Warm; Lothar Müller; Georg Heinrich; Valentina Nekljudova; Gunter von Minckwitz

首页> 外文期刊>Cancer Chemotherapy and Pharmacology >Phase I dose finding study evaluating the combination of bendamustine with weekly paclitaxel in patients with pre-treated metastatic breast cancer: RiTa trial

【24h】

Phase I dose finding study evaluating the combination of bendamustine with weekly paclitaxel in patients with pre-treated metastatic breast cancer: RiTa trial

机译：评估转移性乳腺癌患者苯达莫司汀与每周紫杉醇联合治疗的I期剂量发现研究：RiTa试验

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Purpose The aim of the RiTa trial is to establish a feasible combination of bendamustine and paclitaxel in a weekly schedule in anthracycline pre-treated metastatic breast cancer patients.

机译：目的RiTa试验的目的是在蒽环类药物预处理的转移性乳腺癌患者中每周一次建立苯达莫司汀和紫杉醇的可行组合。

著录项

来源
《Cancer Chemotherapy and Pharmacology》 |2009年第5期|p.953-958|共6页
作者
Sibylle Loibl; Caroline Murmann; Katrin Schwedler; Mathias Warm; Lothar Müller; Georg Heinrich; Valentina Nekljudova; Gunter von Minckwitz;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Phase I dose finding study evaluating the combination of bendamustine with weekly paclitaxel in patients with pre-treated metastatic breast cancer: RiTa trial. [J] . Loibl S, Murmann C, Schwedler K, Cancer chemotherapy and pharmacology. . 2009,第5期

机译：一期剂量寻找研究评估了苯达莫司汀与每周紫杉醇联合治疗转移性乳腺癌的患者：RiTa试验。
2. Multicenter Phase II Study with Weekly Bendamustine and Paclitaxel as First- or Later-Line Therapy in Patients with Metastatic Breast Cancer: RiTa II Trial [J] . Sibylle Loibl, Gabriele Doering, Lothar Miiller, Breast care . 2011,第6期

机译：多中心II期研究，每周使用苯达莫司汀和紫杉醇作为转移性乳腺癌患者的一线或后线治疗：RiTa II试验
3. Multicenter Phase II Study with Weekly Bendamustine and Paclitaxel as First- or Later-Line Therapy in Patients with Metastatic Breast Cancer: RiTa II Trial [J] . Sibylle Loibl, Gabriele Doering, Lothar Müller, Breast care . 2011,第6期

机译：多中心II期研究，每周使用苯达莫司汀和紫杉醇作为转移性乳腺癌患者的一线或后线治疗：RiTa II试验
4. Phase I/II clinical trials on the effect of weekly paclitaxel (wPTX) and wPTX containing combination regimens for advanced and metastatic gastric cancer -ECRIN group studies [C] . Sakamoto J, Kodera Y, Kobayashi M, International Gastric Cancer Congress . 2009

机译：I / II期临床试验关于每周紫杉醇（WPTX）和WPTX含有晚期和转移性胃癌组合方案的临床试验 - 分泌组研究
5. Enhancement of Gemcitabine and Paclitaxel Uptake and Retention in Metastatic Cancer Cells: A Novel Targeted Combination Delivery Approach to Eliminate Breast Cancer in Blood and Lymph [D] . Yu, Jesse. 2020

机译：吉西他滨和紫杉醇吸收的增强和转移性癌细胞的保留：一种小型靶向组合递送方法，消除血液和淋巴中的乳腺癌
6. Multicenter Phase II Study with Weekly Bendamustine and Paclitaxel as First- or Later-Line Therapy in Patients with Metastatic Breast Cancer: RiTa II Trial [O] . Sibylle Loibl, Gabriele Doering, Lothar Müller, 2011

机译：多中心II期研究每周使用苯达莫司汀和紫杉醇作为转移性乳腺癌患者的一线或后线治疗：RiTa II试验
7. Phase II trial of weekly nab (nanoparticle albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane®) in combination with gemcitabine in patients with metastatic breast cancer (N0531) [O] . Roy, V., LaPlant, B. R., Gross, G. G., 2008

机译：转移性乳腺癌患者每周一次纳布（纳米颗粒结合白蛋白）-紫杉醇（纳布-紫杉醇）（Abraxane®）联合吉西他滨的II期临床试验（N0531）

Phase I dose finding study evaluating the combination of bendamustine with weekly paclitaxel in patients with pre-treated metastatic breast cancer: RiTa trial

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅